乳腺病理パーフェクトアトラス

出版社： 中山書店
著者：
発行日： 2023-06-28
分野： 臨床医学：基礎  >  臨床病理学
ISBN： 9784521750019
電子書籍版： 2023-06-28 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：4～8営業日

27,500 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

27,500 円(税込)

購入する

商品紹介

乳腺病理の第一人者，黒住昌史先生が選び抜いて集めた400点超の乳腺病理写真に加え，疾患別に簡潔な解説を加えた，乳腺病理診断の新しいスタンダード．
乳腺病理の専門家だけでなく，乳腺外科の医師にも書棚に常備必至の乳腺病理アトラスです．
新しいWHO分類第5版に基づいて解説されており，より現在の病理診断に役立つ書籍となっています．

目次

  • 第1部　病理診断の実際
    　　針生検標本の病理診断
    　　手術標本の病理診断
    　　予後および薬物療法にかかわる病理診断
    　　　核異型度・組織異型度
    　　　リンパ管侵襲
    　　　バイオマーカー
    　　センチネルリンパ節生検の病理診断
    　　術前療法の効果判定

    第2部　正常乳房の発生，肉眼解剖，組織像
    　　正常乳房の発生
    　　乳房の肉眼解剖
    　　乳房の組織像

    第3部　組織型診断
    　上皮性腫瘍
    　　良性上皮増殖性病変と前駆病変
    　　通常型乳管過形成
    　　平坦型上皮異型を含む円柱状細胞病変
    　　異型乳管過形成
    　腺症と硬化性病変
    　　硬化性腺症
    　　アポクリン腺症
    　　放射状瘢痕・複合硬化性病変
    　腺腫
    　　管状腺腫
    　　乳管腺腫
    　　微小腺管腺症
    　上皮・筋上皮腫瘍
    　　腺筋上皮腫
    　乳頭状病変
    　　乳管内乳頭腫
    　　乳頭状非浸潤性乳管癌
    　　被包型乳頭癌
    　　充実乳頭癌
    　　浸潤性乳頭癌
    　非浸潤性小葉腫瘍
    　　異型小葉過形成
    　　非浸潤小葉癌
    　非浸潤性乳管癌
    　浸潤癌
    　　浸潤性乳癌・非特殊型
    　　微小浸潤癌
    　　浸潤性小葉癌
    　　管状癌
    　　篩状癌
    　　粘液癌
    　　浸潤性微小乳頭癌
    　　アポクリン分化を伴う癌
    　　化生癌
    　まれで唾液腺型の癌
    　　腺様?胞癌
    　　分泌癌
    　神経内分泌新生物
    　　神経内分泌腫瘍
    　　神経内分泌癌
    　線維上皮性腫瘍と過誤腫
    　　過誤腫
    　　線維腺腫
    　　葉状腫瘍
    　乳頭の腫瘍
    　　乳頭部腺腫
    　　乳房Paget病
    　間葉系腫瘍
    　　血管肉腫
    　　末梢神経鞘腫瘍
    　　腫瘍様病変
    　悪性リンパ腫
    　　びまん性大細胞型B 細胞リンパ腫
    　男性乳腺腫瘍
    　　女性化乳房
    　　男性（男子）乳癌

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

[第1部] 病理診断の実際

P.7 掲載の参考文献
日本乳癌学会 編:針生検. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, pp.83-84.
 
黒住昌史:細胞診・組織診. 再発乳癌治療ガイドブック. 東京:南江堂;2002, pp.85-90.
 
黒住昌史:<特集>微小乳癌の診断法-穿刺吸引細胞診. 臨床と研究. 82:1629-1633, 2005.
Medical*Online
黒住昌史:針生検標本の病理診断. <癌診療指針のための病理診断プラクティス>乳癌. 東京:中山書店;2011, pp.26-30.
 
Bilous M:Breast core needle biopsy:issues and controversies. Mod Pathol. 23(supple 2):S36-45, 2010.
 
Denisson G, et al. :A prospective study of the use of fine-needle aspiration cytology and core biopsy in diagnosis of breast cancer. Breast J. 9:491-493, 2003.
 
Hicks DG, Lester SC:Core needle biopsies. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.30-41.
 
Layfield LJ, et al. :Histomorphologic features of biopsy sites following excisional and core needle biopsies of the breast. Breast J. 21:370-376, 2015.
PubMed
Lee AH, et al. :The value of examination of multiple levels of mammary needle core biopsy specimens taken for investigation of lesions other than calcification. J Clin Pathol. 65:1097-1099, 2012.
PubMed
Leifland K, et al. :Comparison of stereotactic fine needle aspiration cytology and core needle biopsy in 522 non-palpable breast lesions. Acta Radiol. 44:387-391, 2003.
PubMed
Poole BB, et al. :Malignancy rates after surgical excision of discordant breast biopsies. J Surg Res. 195:152-157, 2015.
PubMed
P.22 掲載の参考文献
日本乳癌学会 編:切除標本の組織学的取扱いと記載法. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, pp.68-75.
 
Hicks DG, Lester SC:Excisions. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.42-47.
 
Hicks DG, Lester SC:Margins and reexcisions. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.48-53.
 
Hicks DG, Lester SC:Mastectomies. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.54-59.
 
Moran MS, et al. :Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Ann Surg Oncol. 21:704-716, 2014.
PubMed
Morrow M, et al. :Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Pract Radiat Oncol. 6:287-295, 2016.
 
P.24 掲載の参考文献
日本乳癌学会 編:病理学的グレード分類. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, pp.73-74.
 
市原 周, 中井登紀子:乳癌の悪性度評価. 乳癌, 第2版. 東京:文光堂;2016, pp.233-236.
 
黒住昌史:病理学的悪性度分類とその臨床応用. みんなに役立つ乳癌の基礎と臨床. 大阪:医薬ジャーナル;2009, pp.352-360.
 
Rakha EA:Invasive breast carcinoma. General overview. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.82-88.
 
Tan PH, Ellis IO:Introduction to tumours of the breast. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.6-7.
 
P.28 掲載の参考文献
日本乳癌学会 編:脈管侵襲の有無. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.72.
 
Goldhirsch A, et al. :Meeting highlight:International expert consensus on the primary therapy of early breast cancer 2005. Arch Oncol. 16:1569-1583, 2005.
 
Hicks DG, Lester SC:Lymph-vascular invasion. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.422-429.
 
Kurosumi M, et al. :Relationship between existence of lymphatic invasion in peritumoral breast tissue and presence of axillary lymph node metastasis in invasive ductal carcinoma of the breast. Oncology Rep.8:1051-1055, 2001.
PubMed
P.37 掲載の参考文献
日本乳癌学会 編:バイオマーカー検査と判定基準. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, pp.87-93.
 
日本病理学会 編:乳癌・胃癌 HER2 病理診断ガイドライン, 第2版. 東京:金原出版;2021, pp.1-90.
 
黒住昌史:乳腺疾患の臨床. 東京:金原出版;2006, pp.91-95.
 
Allison KH, et al. :Estrogen and Progesterone Receptor Testing in Breast Cancer:ASCO/CAP Guideline Update. J Clin Oncol. 38:1346-1366, 2020.
PubMed
Allred DC, et al. :Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 11:155-168, 1998.
PubMed
Hicks DG, Lester SC:Hormone receptor(ER/PR). In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.430-439.
 
Hicks DG, Lester SC:HER2. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.440-451.
 
Kurosumi M:Significance of immunohistochemical assessment of steroid hormone receptor status for breast cancer patients. Breast Cancer. 10:97-104, 2003.
PubMed
Kurosumi M:Immunohistochemical assessment of hormone receptor status using a new scoring system(J-Score)in breast cancer. Breast Cancer. 14:189-193, 2007.
PubMed
Nitta H, et al. :Development of automated brightfield double In Situ hybridization(BDISH)application for HER2 gene and chromosome 17 centromere(CEN 17)for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization(FISH). Diagn Pathol. 3:41, 2008.
 
Rakha EA:Invasive breast carcinoma. General overview. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.82-101.
 
Wolff AC, et al. :Human epidermal growth factor receptor 2 testing in breast cancer:American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update. J Clin Oncol. 36:2105-2122, 2018.
 
Goldhirsch A et al. :Personalizing the treatment of woman with early breast cancer:highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer. Ann Oncol 24:2206-2203, 2013.
PubMed
P.47 掲載の参考文献
日本乳癌学会 編:センチネルリンパ節に関する記載法. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.71.
 
日本乳癌学会 編:TNM分類. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, pp.103-109.
 
Chu KU, et al. :Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg. 229:536-541, 1999.
 
Cox CE, et al. :Guideline for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg. 5:645-653, 1998.
PubMed
European Working Group for Breast Screening Pathology:Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer. 39:1654-1667, 2003.
 
Giuliano AE, et al. :Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 220:391-401, 1994.
PubMed
International Agency for Research on Cancer(IARC):WHO histological classification of tumours of the breast. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.10-12.
 
Krag DN, et al. :Surgical resection and radiolocalization of the sentinel node in breast cancer using a gamma probe. Surg Oncol. 2:335-340, 1993.
PubMed
Kurosumi M, Takei H:Significance and problems of histopathological examination and utility of real-time reverse transcriptase-polymerase chain reaction method for the detection of sentinel lymph node metastasis in breast cancer. Breast Cancer. 14:342-349, 2007.
PubMed
Schwartz GF, et al. :Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer. 94:2542-2551, 2002.
 
Takei H, et al. :Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer cases. Breast Cancer. 9:344-348, 2002.
PubMed
Veronesi U, et al. :Sentinel-lymph-node biopsy as a staging procedure in breast cancer:update of a ramdomised controlled study. Lancet Oncol. 7:983-990, 2006.
 
P.52 掲載の参考文献
日本乳癌学会 編:組織学的治療効果の判定基準. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, pp.94-95.
 
Bear HD, et al. :National Surgical Adjuvant Breast and Bowel Project Protocol B-27:The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide:preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol. 21:4165-4174, 2003.
PubMed
Brierley JD, et al. :The "y" symbol:an important classification tool for neoadjuvant cancer treatment. Cancer. 106:2526-2527, 2006.
 
Fisher B, et al. :Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer:Findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 15:2483-2493, 1997.
PubMed
Heys SD, et al. :Aberdeen Breast Group:Neoadjuvant docetaxel in breast cancer:3-year survival results from the Aberdeen trial. Clin Breast Cancer. 3 Suppl2:S69-74, 2002.
 
Kurosumi M, et al. :Histopathological criteria for assessment of therapeutic response in breast cancer. Breast Cancer. 8:1-2, 2001.
PubMed
Kurosumi M:Significance of histopathological evaluation in primary therapy for breast cancer. Recent trends in primary modality with pathological complete response(pCR)as endpoint. Breast Cancer. 11:139-147, 2004.
PubMed
Kurosumi M, et al. :Histopathological criteria for assessment of therapeutic response in breast cancer(2007 version). Breast Cancer. 15:5-7, 2008.
PubMed
Kurosumi M, et al. :Histopathological assessment of anastrozole and tamoxifen as preoperative(neoadjuvant)treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial. J Cancer Res Clin Oncol. 134:715-722, 2008.
 
Mukai H, et al. :Safety and efficacy trial of preoperative sequential chemo-radiation therapy for the nonsurgical treatment(NST)in early breast cancer(EBC):Japan Clinical Oncology Group trial(JCOG0306). J Clin Oncol. 26(15 suppl):601, 2008.
 

[第2部] 正常乳房の発生, 肉眼解剖, 組織像

P.63 掲載の参考文献
秋田恵一, 佐藤達夫:乳房の発生と分化. <新女性医学大系 20>乳房とその疾患. 東京:中山書店;1999, pp.11-15.
 
黒住昌史, 坂本允弘:ヒト授乳期乳腺と分泌機能を有する特殊型乳癌の電子顕微鏡学的所見. 日本臨床電顕会誌 3:9-30, 2000.
 
黒住昌史:正常乳房の解剖と組織像. 乳腺疾患の臨床. 東京:金原出版;2006, pp.2-6.
 
黒住昌史:正常乳房の解剖学的構造と組織像. 石栗一男(編), 乳腺-画像と検査. 東京:医療科学社;2019, pp.17-22.
 
Hicks DG, Lester SC:Histology of normal breast. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.4-13.
 
Merkel F(neu bearbeitet):J. Henle's Grundriss der Anatomie des Menschen, Atlas, 4th ed. Braunschweig:Friedrich Vieweg und Sohn;1901, p.247.
 
Moore KL(著)/瀬口春道(監訳):乳腺の発生. ムーア人体発生学, 原著第6版. 東京:医歯薬出版;2001, pp.545-547.
 
Netter FH(著)/相磯貞和(訳):乳腺. ネッター解剖学アトラス, 原書第6版. 東京:南江堂;2016, 図 179.
 
Rosen PP:Anatomy and physiologic morphology. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.1-22.
 
Tavassoli FA:Structure of the adult duct system. In:Pathology of the Breast, 2nd ed. Stamford:Appleton & Lange;1999, p.4.
 

[第3部] 組織型診断

P.73 掲載の参考文献
日本乳癌学会 編:乳管過形成. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.35.
 
Collins L, et al. :Usual ductal hyperplasia. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.84-85.
 
Collins LC:Precursor lesions of the low-grade breast neoplasia pathway. Surg Pathol Clin. 11:177-197, 2018.
PubMed
Hicks DG, Lester SC:Atypical ductal hyperplasia. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.168-175.
 
Hoda SA:Ductal hyperplasia:usual and atypical. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.290-335.
 
Lakhani SR, et al. :Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal neoplastic proliferations. Lab Invest. 74:129-135, 1996.
PubMed
Liu H:Application of immunohistochemistry in breast pathology:a review and update. Arch Pathol Lab Med. 138:1629-1642, 2014.
 
Peng Y, et al. :Update on immunohistochemical analysis in breast lesions. Arch Pathol Lab Med. 141:1033-1051, 2017.
PubMed
Schnitt SJ, et al. :Usual ductal hyperplasia. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.13-14.
 
Tavassoli FA, et al. :Usual ductal hyperplasia. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.64-65.
 
P.77 掲載の参考文献
日本乳癌学会 編:異型上皮内病変. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.27.
 
Aulmann S, et al. :Transitions between flat epithelia atypia and low-grade ductal carcinoma in situ of the breast. Am J Surg Pathol. 36:1247-1252, 2012.
 
Hanby AM, et al. :Columnar cell change and hyperplasia. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, p.86.
 
Hicks DG, Lester SC:Columnar cell change, columnar cell hyperplasia and flat epithelia atypia. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.100-107.
 
Hoda SA:Columnar cell lesions as a form of ductal hyperplasia:usual and atypical. In:Hoda SA, et al. , editors, Rosen's Breast Pathology. 5th ed. , Philadelphia:Wolters Kluwer;2021, pp.314-318.
 
Hoda SA:Histopathology of atypical columnar cell hyperplasia/flat epithelial atypia. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.318-325.
 
Schnitt SJ, et al. :Flat epithelia atypia. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, p.87.
 
Schnitt SJ, et al. :Columnar cell lesions including flat epithelia atypia. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.15-17.
 
Tavassoli FA, et al:Flat epithelia atypia. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.65-66.
 
P.81 掲載の参考文献
日本乳癌学会 編:異型上皮内病変. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.27.
 
Allison KH, et al. :Atypical ductal hyperplasia. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.18-21.
 
Farshid G, et al. :Active surveillance of women diagnosed with atypical ductal hyperplasia on core needle biopsy may share many women potentially unnecessary surgery, but at the risk of undertreatment for minority:10-year surgical outcomes of 114 consecutive cases from a single center. Mod Pathol. 31:395-405, 2018.
 
Hartmann LC, et al. :Understanding the premalignant potential of atypical hyperplasia through its natural history:a longitudinal cohort study. Cancer Prev Res(Phila). 7:211-217, 2014.
PubMed
Hartmann LC, et al. :Atypical hyperplasia of the breast-risk assessment and management options. N Eng J Med. 372:78-89, 2015.
 
Hicks DG, Lester SC:Atypical ductal hyperplasia. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.168-175.
 
Hoda SA:Ductal hyperplasia:usual and atypical. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.290-335.
 
Simpson JF, et al. :Atypical ductal hyperplasia. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.88-89.
 
Tavassoli FA, et al:Atypical ductal hyperplasia. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.66-67.
 
Tozbikian G, et al. :Atypical ductal hyperplasia bordering on ductal carcinoma in situ. Int J Surg Pathol. 25:100-107, 2017.
PubMed
P.85 掲載の参考文献
日本乳癌学会 編:硬化性腺症. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.35.
 
Bussolati G, et al. :Usual ductal hyperplasia. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, p.81.
 
Friedenreich C, et al. :Risk factors for benign proliferative breast disease. Int J Epidemiol. 29:637-644, 2000.
PubMed
Hicks DG, Lester SC:Sclerosing adenosis. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.126-133.
 
Hoda SA:Sclerosing adenosis. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.194-200.
 
Jensen RA, et al. :Invasive breast cancer risk in women with sclerosing adenosis. Cancer. 64:1977-1983, 1989.
PubMed
Oberman HA, et al. :Noninvasive carcinoma of the breast presenting in adenosis. Mod Pathol. 4:31-35, 1991.
PubMed
Sahin A, et al. :Sclerosing adenosis. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.22-24.
 
Simpson JF, et al. :Adenosis, sclerosing adenosis and apocrine adenosis. In:Lakhani SR, et al., editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.112-113.
 
Visscher DW, et al. :Sclerosing adenosis and risk of breast cancer. Breast Cancer Res Treat. 144:205-212, 2014.
PubMed
P.89 掲載の参考文献
Bussolati G, et al. :Apocrine adenosis. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, p.82.
 
Carter DJ, et al. :Atypical apocrine adenosis in sclerosing lesions of the breast. Mod Pathol. 4:1-5, 1991.
PubMed
Celis JE, et al. :Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia. Mol Oncol. 1:97-119, 2007.
PubMed
Elayat G, et al. :Cell cycle alterations and their relationship to proliferation in apocrine adenosis of the breast. Histopathology. 54:348-354, 2009.
PubMed
Hicks DG, Lester SC:Sclerosing adenosis. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.126-133.
 
Wen HY, Brogi E:Apocrine adenosis. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.200-202.
 
Sahin A, et al. :Apocrine adenosis and adenoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.25-27.
 
Seidman JD, et al. :Atypical apocrine adenosis of the breast:a clinicopathologic study of 37 patients with 8.7-year follow-up.Cancer. 77:2529-2537, 1996.
PubMed
Selim AG, et al. :Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast. Virchows Arch. 441:449-455, 2002.
 
Simpson JF, et al. :Adenosis, sclerosing adenosis and apocrine adenosis. In:Lakhani SR, et al., editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.112-113.
 
P.93 掲載の参考文献
Bussolati G, et al. :Radial scar/complex sclerosing lesion. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.82-84.
 
Ellis IO, et al. :Radial scar and complex sclerosing lesion. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.114-115.
 
Hicks DG, Lester SC:Radial sclerosing lesion/Radial scar. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.140-145.
 
Hilton JB, et al. Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast. Am J Surg Pathol. 34:896-900, 2010.
 
Koerner FC:Radial sclerosing lesion. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.114-123.
 
Nassar A, et al. :Radial scar and complex sclerosing lesions:a clinicopathologic correlation study from a single institution. Ann Diagn Pathol. 19:24-28, 2015.
 
Oh EY, et al. :Keratin expression patterns in stromal cells of benign sclerosing lesions of the breast:a potential diagnostic pitfall. Arch Pathol Lab Med. 139:1143-1148, 2015.
PubMed
Sahin A, Collins LC:Radial scar/complex sclerosing lesion. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.30-31.
 
Wilsher MJ:Adenosquamous proliferation of the breast and low grade adenosquamous carcinoma:a common precursor of an uncommon cancer? Pathology. 46:402-410, 2014.
PubMed
Wolters KL, et al. :Frequent PIK3CA mutations in radial scars. Diagn Mol Pathol. 22:210-214, 2013.
PubMed
P.97 掲載の参考文献
日本乳癌学会 編:管状腺腫. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.26.
 
Bezic J, et al. :Combined fibroadenoma and tubular adenoma of the breast:rare presentation that confirms common histogenesis. Breast J. 21:309-311, 2015.
PubMed
Brogi E:Tubular adenoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.243-244.
 
Bussolati G, et al. :Tubular adenoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, p.84.
 
Foschini MP,et al. :Tubular adenoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, p.115.
 
Jaffer SM, et al:Tubular adenoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.32-34.
 
Kuijper A, et al. :Histopathology of fibroadenoma of the breast. Am J Clin Pathol. 115:736-742, 2001.
PubMed
Moross T, et al. :Tubular adenoma of the breast. Arch Pathol Lab Med. 107:84-86, 1983.
PubMed
Tay TK, et al. :Paediatric fibroepithelial lesions revisited:pathological insights. J Clin Pathol. 68:633-641, 2015.
PubMed
Volckmar AL, et al. :Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K-AKT pathway. Genes Chromosomes Cancer. 56:11-17, 2017.
PubMed
P.101 掲載の参考文献
日本乳癌学会 編:乳管腺腫. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.26.
 
黒住昌史:乳管腺腫. <病理と臨床 Vol. 15 臨時増刊>病理学キーワード. 東京:文光堂;1997, p.353.
 
黒住昌史:Ductal adenoma. 病理と臨床 19:381-384, 2001.
Medical*Online
黒住昌史:乳管腺腫 ductal adenoma. 良性乳腺疾患アトラス-乳腺診療の手引き. 大阪:永井書店;2005, pp.158-161.
 
Brogi E, et al. :Ductal adenoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, p.244.
 
Bussolati G, et al. :Ductal adenoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, p.85.
 
Foschini MP,et al. :Ductal adenoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, p.117.
 
Jaffer SM, et al. :Ductal adenoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.37-38.
 
Troxell ML, et al. :High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast. Mod Pathol. 23:27-37, 2010.
PubMed
Volckmar AL, et al. :Tubular, lactating, and ductal adenomas are devoid of MED12 Exon2 mutations, and ductal adenomas show recurrent mutations in GNAS and the PI3K-AKT pathway. Genes Chromosomes Cancer. 56:11-17, 2017.
PubMed
P.105 掲載の参考文献
Bussolati G, et al. :Microglandular adenosis. In:Tavassoli FA, Devilee P,editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, p.82.
 
Choi JE, et al. :Invasive breast carcinoma arising in microglandular adenosis:two case reports. J Breast Cancer. 16:432-437, 2013.
PubMed
Falleti J, et al. :Acinic cell carcinoma of the breast arising in microglandular adenosis. Case Rep Pathol. 2013:736048, 2013.
PubMed
Geyer FC, et al. :Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis. Histopathology. 60(6B):E115-130. 2012.
PubMed
Hicks DG, Lester SC:Microglandular adenosis. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.162-167.
 
Sahin A, Collins LC:Microglandular adenosis. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.28-29.
 
Shin SJ, Gobbi H:Microglandular adenosis, atypical microglandular adenosis and microglandular adenosis with carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.113-114.
 
Wen YH, et al. :Microglandular adenosis:a non-obligate precursor of triple-negative breast cancer? Histol Histopathol. 28:1099-1108, 2013.
PubMed
Wen YH, Brogi E:Microglandular adenosis. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.209-224.
 
Zhong F, et al. :Carcinoma arising in microglandular adenosis of the breast:triple negative phenotype with variable morphology. Int J Clin Exp Pathol. 7:6149-6156, 2014.
PubMed
P.109 掲載の参考文献
日本乳癌学会 編:腺筋上皮腫. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, pp.26-27.
 
Brogi E:Adenomyoepithelioma. In:Hoda SA, et al., editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.163-184.
 
Foschini MP,et al:Adenomyoepithelioma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.43-45.
 
Geyer FC, et al. :Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepithelioma. Nat Commun. 9:1816, 2018.
PubMed
Lakhani SR, et al. :Adenomyoepithelioma and adenomyoepithelioma with carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.122-123.
 
McLaren BK, et al. :Adenomyoepithelioma:clinical, histologic and immunohistologic evaluation of a series of related lesions. Am J Surg Pathol. 29:1294-1299, 2005.
PubMed
Moritani S, et al. :Immunohistochemical expression of myoepithelial markers in adenomyoepithelioma of the breast:a unique paradoxical staining pattern of high-molecular weight cytokeratins. Virchows Arch. 466:191-198, 2015.
PubMed
Moritz AW, et al. :Breast adenomyoepithelioma and adenomyoepithelioma with carcinoma(malignant adenomyoepithelioma)with associated breast malignancies:a case series emphasizing histologic, radiologic, and clinical correlation. Breast. 29:132-139, 2016.
PubMed
Rosen PP:Adenomyoepithelioma of the breast. Hum Pathol. 18:1232-1237, 1987.
PubMed
Tavassoli FA, Soares J:Adenomyoepithelioma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.87-88.
 
P.113 掲載の参考文献
日本乳癌学会 編:乳管内乳頭腫. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.26.
 
Di Cristofano C, et al. :Papillary lesions of the breast:a molecular progression? Breast Cancer Res Treat. 90:71-76, 2005.
PubMed
Greif F, et al. :Carcinoma within solitary ductal papilloma of the breast. Eur J Surg Oncol. 36:384-386, 2010.
PubMed
Hicks DG, Lester SC:Papilloma, large duct and small duct. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.146-155.
 
Koerner FC:Papilloma and related benign lesions. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.100-157.
 
MacGrogan G, et al. :Intraductal papilloma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.76-78.
 
Nagi C, et al. :Epithelial displacement in breast lesions:a papillary phenomenon. Arch Pathol Lab Med. 129:1465-1469, 2005.
PubMed
O'Malley F, et al. :Intraductal papilloma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.100-102.
 
Troxell ML et al. :Intraductal papilloma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.52-56.
 
Yoshida M, et al. :Loss of heterozygosity on chromosome 16q suggests malignancy I core needle biopsy specimens of intraductal papillary breast lesions. Virchows Arch. 460:497-504, 2012.
PubMed
P.119 掲載の参考文献
日本乳癌学会 編:非浸潤性乳管癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.27.
 
Basavaiah SH, et al. :Diagnostic Pitfalls in Papillary Lesions of the Breast:Experience from a Single Tertiary Care Center. J Clin Diagn Res. 10(8):EC18-EC21, 2016.
 
Brogi E, et al. :Papillary ductal carcinoma in situ. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.57-59.
 
Hashmi AA, et al. :Spectrum of Papillary Breast Lesions According to World Health Organization Classification of Papillary Neoplasms of Breast. Cureus. 12(10):e11026, 2020.
 
Koerner FC:Noninvasive papillary carcinoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.541-546.
 
Kulka J, et al. :Papillary lesions of the breast. Virchows Arch. 480:65-84, 2022.
PubMed
MacGrogan G, et al. :Intraductal papillary carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.103-105.
 
Tavassoli FA, et al. :Intraductal papillary carcinoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.78-98.
 
Vdovenko AA:Pathology of breast papillary neoplasms:Community hospital experience. Ann Diagn Pathol. ;49:151605, 2020.
PubMed
Wang H, et al. :Follow-up of breast papillary lesion on core needle biopsy:experience in African-American population. Diagn Pathol. 2014;9:86.
PubMed
P.123 掲載の参考文献
日本乳癌学会 編:被包型乳頭癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.27.
 
Collins L, et al. :Encapsulated papillary carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.106-107.
 
Cui X, et al. :Composite encapsulated papillary carcinoma and solid papillary carcinoma. Pathol Int. 65:133-137, 2015.
PubMed
Esposito NN, et al:Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study 27 cases. Am J Clin Pathol. 131:228-242, 2009.
PubMed
George K, et al. :Encapsulated papillary carcinoma of the breast:An overview. J Cancer Res Ther. 9:564-570, 2013.
PubMed
Hicks DG, Lester SC:Encapsulated papillary carcinoma. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.232-237.
 
Koerner FC:Encapsulated papillary carcinoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, p.555.
 
MacGrogan G, et al. :Encapsulated papillary carcinoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.60-62.
 
Piscuoglio S, et al. :Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast. Mol Oncol. 8:1588-1602, 2014.
PubMed
Rakha EA, et al:High-grade encapsulated papillary carcinoma of the breast:an under-recognized entity. Histopathology. 66:740-746, 2015.
PubMed
P.127 掲載の参考文献
日本乳癌学会 編:非浸潤性乳管癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.27.
 
Koerner FC:Solid papillary carcinoma with neuroendocrine features. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.555-561.
 
MacGrogan G, et al. :Solid papillary carcinoma(in situ and invasive). In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.63-65.
 
Maluf HM, et al. :Solid papillary carcinoma of the breast. A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma. Am J Surg Pathol. 19:1237-1244, 1995.
 
Nicolas MM, et al. :Loss of myoepithelium is variable in solid papillary carcinoma of the breast. Histopathology. 51:657-665, 2007.
PubMed
Oh EJ, et al. :Correlation between solid papillary carcinoma and associated invasive carcinoma according to expression of WT1 and several MUCs. Pathol Res Pract. 210:953-958, 2014.
PubMed
Otsuki Y, et al. :Solid-papillary carcinoma of the breast:clinicopathological study of 20 cases. Pathol Int. 57:421-429, 2007.
PubMed
Tariq MU, et al. :Solid papillary carcinoma of breast;a detailed clinicopathological study of 65 cases of uncommon breast neoplasm with literature review. Breast J. 26:211-215, 2020.
PubMed
Visscher D, et al. :Solid papillary carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.108-109.
 
You C, et al. :Solid papillary carcinoma of breast:magnetic resonance mammography, digital mammography, and ultrasound findings. J Comput Assist Tomogr. 42:771-775, 2018.
PubMed
P.131 掲載の参考文献
日本乳癌学会 編:浸潤性乳頭癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.32.
 
Ellis IO, et al. :Invasive papillary carcinoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.34-35.
 
Hicks DG, Lester SC:Invasive papillary carcinoma. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.292-297.
 
Koerner FC:Invasive papillary carcinoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.548-553.
 
Liu ZY, et al. :Clinicopathologic characteristics and molecular subtypes of invasive papillary carcinoma of the breast:a large case study. J Cancer Res Clin Oncol. 139:77-84, 2013.
PubMed
MacGrogan G. et al. :Invasive papillary carcinoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.66-67.
 
Piscuoglio S, et al. :Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast. Mol Oncol. 8:1588-1602, 2014.
PubMed
Tse G et al. :Invasive papillary carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, p.64.
 
Ueng SH, et al. :Papillary neoplasms of the breast:a review. Arch Pathol Lab Med. 133:893-907, 2009.
PubMed
Wei S:Papillary lesions of the breast:an update. Arch Pathol Lab Med. 140:628-643, 2016.
PubMed
P.135 掲載の参考文献
日本乳癌学会 編:異型上皮内病変. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.27.
 
Chen YY, et al. :Atypical lobular hyperplasia. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.68-70.
 
Hicks DG, Lester SC:Atypical lobular hyperplasia. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.176-181.
 
Hoda SA:Lobular carcinoma in situ and atypical lobular hyperplasia. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.886-944.
 
Hwang H, et al. :Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens:routine excision is not necessary. Mod Pathol. 21:1208-1216, 2008.
 
Lakhani SR, et al. :Lobular neoplasia. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.78-80.
 
Mastracci TL, et al. :E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast. Mod Pathol. 18:741-751, 2005.
PubMed
Page DL, et al. :Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk:a retrospective cohort study. Lancet. 361(9352):125-129, 2003.
 
Subhawong AP,et al. :Incidental minimal atypical lobular hyperplasia on core needle biopsy:correlation with findings on follow-up excision. Am J Surg Pathol. 34:822-828, 2010.
PubMed
Tavassoli FA, et al:Lobular neoplasia. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.60-62.
 
P.139 掲載の参考文献
日本乳癌学会 編:非浸潤性小葉癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.28.
 
Boldt V, et al. :Positioning of necrotic lobular intraepithelial neoplasias(LIN, grade 3)within the sequence of breast carcinoma progression. Genes Chromosomes Cancer. 49:463-470. 2010.
PubMed
Carder PJ, et al. :Screen-detected pleomorphic lobular carcinoma in situ(PLCIS):risk of concurrent invasive malignancy following a core biopsy diagnosis. Histopathology. 57:472-478, 2010.
PubMed
Chen YY, et al. :Lobular carcinoma in situ. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.71-74.
 
Hanby AM, et al. :In situ and invasive lobular neoplasia of the breast. Histopathology. 52:58-66, 2008.
PubMed
Hicks DG, Lester SC:Lobular carcinoma in situ. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.190-201.
 
Hoda SA:Lobular carcinoma in situ and atypical lobular hyperplasia. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.886-944.
 
Lakhani SR, et al. :Lobular neoplasia. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.78-80.
 
Tavassoli FA, et al:Lobular neoplasia. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.60-62.
 
P.144 掲載の参考文献
日本乳癌学会 編:非浸潤性乳管癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.27.
 
Cowell CF, et al. :Progression from ductal carcinoma in situ to invasive breast cancer:revisited. Mol Oncol. 7:859-869, 2013.
PubMed
Hicks DG, Lester SC:Ductal carcinoma in situ. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.202-215.
 
Hoda SA:Ductal carcinoma in situ. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.363-450.
 
Pinder SE:Ductal carcinoma in situ(DCIS):pathological features, differential diagnosis, prognostic factors and specimen evaluation. Mol Pathol. 23 Suppl 2:S8-S13, 2010.
 
Pinder SE, et al. :Ductal carcinoma in situ. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.76-81.
 
Ross DS, et al. :Ductal carcinoma in situ:morphology-based knowledge and molecular advances. Adv Anal Pathol. 20:205-216, 2013.
 
Schnitt SJ, et al. :Ductal carcinoma in situ. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.90-94.
 
Solin LJ, et al. :A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst. 105:701-710, 2013.
PubMed
Tavassoli FA, et al:Ductal carcinoma in situ(DCIS). In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.67-73.
 
P.153 掲載の参考文献
日本乳癌学会 編:浸潤性乳管癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, pp.28-29.
 
黒住昌史:組織型分類. よくわかる乳癌のすべて(飯野佑一ほか 編). 大阪:永井書店;2006, pp.184-195.
 
黒住昌史:悪性疾患. 乳腺疾患の臨床(坂元吾偉ほか 監). 東京:金原出版;2006, pp.57-66.
 
Ellis IO, et al. :Invasive ductal carcinoma, not otherwise specified(NOS). In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.19-23.
 
Ellis IO, et al. :Invasive carcinoma of no special type. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.34-38.
 
Hicks DG, Lester SC:Invasive ductal carcinoma(adenocarcinomas of no special type). In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.238-247.
 
Hicks DG, Lester SC:Carcinoma with extensive intraductal component. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.382-385.
 
Hoda RS, Hoda SA:Invasive ductal carcinoma:assessment of prognosis with morphologic and biologic markers. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.451-515.
 
Kurosumi M, et al. :Prognostic significance of scoring system based on histological heterogeneity of invasive ductal carcinoma for node-negative breast cancer patients. Oncol Rep.10:833-837, 2003.
PubMed
Rakha EA, et al. :Invasive breast carcinoma of no special type. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.102-109.
 
P.159 掲載の参考文献
日本乳癌学会 編:髄様癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.30.
 
Ellis IO, et al. :Medullary carcinoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.28-29.
 
Farshid G, et al. :Morphology of breast cancers as a means of triage of patients for BRCA1 genetic testing. Am J Surg Pathol. 30:1357-1366, 2006.
PubMed
Hicks DG, Lester SC:Carcinoma with medullary features. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.276-281.
 
Huober J, et al. :Prognosis of medullary breast cancer:analysis of 13 International Breast Cancer Study Group(IBCSG)trials. Ann Oncol. 23:2843-2851, 2012.
 
Jacquemier J, et al. :Carcinoma with medullary features. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.46-47.
 
Koerner FC:Medullary carcinoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.570-591.
 
Rakha EA, et al. :The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast. Eur J Cancer. 45:1780-1787, 2009.
 
Rakha EA, et al:Medullary pattern. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.104-105.
 
Vincent-Salomon A, et al. :Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. Breast Cancer Res. 9:R24, 2007.
PubMed
P.163 掲載の参考文献
日本乳癌学会 編:神経内分泌癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.32.
 
Brogi E:Mammary carcinomas with endocrine features. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.732-751.
 
Bussolati G, Badve S:Carcinoma with neuroendocrine features. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.62-63.
 
Ellis IO:Neuroendocrine tumours. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.32-34.
 
Hicks DG, Lester SC:Carcinoma with neuroendocrine features. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.372-379.
 
Miremadi A, et al. :Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology. 40:215-222, 2002.
PubMed
Papotti M, et al. :Neuroendocrine differentiation in carcinomas of the breast:a study of 51 cases. Semin Diagn Pathol, 6:174-188, 1989.
PubMed
Rakha EA, et al:Invasive carcinoma with neuroendocrine differentiation. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, p.105.
 
Wang J, et al. :Invasive neuroendocrine carcinoma of the breast:a population-based study from the Surveillance, Epidemiology and End Results(SEER)database. BMC Cancer. 14:147, 2014.
PubMed
Zekioglu O, et al. :Neuroendocrine differentiated carcinomas of the breast:a distinct entity. Breast. 12:251-257, 2003.
PubMed
P.167 掲載の参考文献
黒住昌史, ほか:破骨細胞に類似した多核巨細胞を伴う乳癌の免疫組織化学的検討. 乳癌の臨床 7:69-74, 1992.
Medical*Online
Ellis IO, et al. :Carcinoma with osteoclastic giant cells. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.21-22.
 
Ellis IO. et al. :Carcinoma with osteoclast-like stromal giant cells. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.36-37.
 
Herrington CS, et al:Osteosarcomatous differentiation in carcinoma with osteoclasts and osteoclast-like giant cells. Histopathology. 24:282-285, 1994.
PubMed
Ng WK:Fine needle aspiration cytology of invasive cribriform carcinoma of the breast with osteoclastlike giant cells:a case report. Acta Cytol. 45:593-598, 2001.
PubMed
Phyllipson J, et al. :Fine needle aspiration of invasive cribriform carcinoma with benign osteoclast-like giant cells of histiocytic origin:a case report. Acta Cytol. 38:479-482, 1994.
 
Rakha EA, et al:Carcinoma with osteoclast-like stromal giant cells. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.105-106.
 
Silverman EM, et al. :Metaplastic neoplasms in the breast. Surg Gynecol Obstet. 138:26-28, 1974.
 
Trojani M, et al. :Osteoclastic type giant cell carcinoma of the breast. Ann Pathol. 9:189-194, 1989.
PubMed
Wargotz ES, Norris HJ:Metaplastic carcinoma of the breast:V. Metaplastic carcinoma with osteoclastic giant cells. Hum Pathol. 21:1142-1150, 1990.
PubMed
P.171 掲載の参考文献
Caruso R, et al. :Pleomorphic ductal carcinoma of the male breast:report of a rare case and review of literature. Anticancer Res. 31:3069-3071, 2011.
PubMed
Ellis IO, et al. :Pleomorphic carcinoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, p.21.
 
Ellis IO, et al. :Pleomorphic carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, p.36.
 
Lenicek T, et al. :Pleomorphic ductal carcinoma of the breast with predominant micropapillary features. Pathol Int. 57:694-697, 2007.
PubMed
Nguyen CV, et al. :Pleomorphic ductal carcinoma of the breast:predictors of decreased overall survival. Am J Surg Pathol. 34:486-493, 2010.
PubMed
Rakha EA, et al:Pleomorphic pattern. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, p.106.
 
Silver SA, et al. :Pleomorphic carcinoma of the breast:clinicopathological analysis of 26 cases of a usual high-grade phenotype of ductal carcinoma. Histopathology. 36:505-514, 2000.
 
Tang H, et al. :Pleomorphic carcinoma of breast:a case report and review of literature. Int J Clin Exp Pathol. 7:5215-5220, 2014.
PubMed
Vranic S, et al:Theranostic molecular profiling of pleomorphic ductal carcinoma of the breast. Breast J. 25:175-176, 2019.
PubMed
Zhao J, et al. :Clinicopathologic characteristics of pleomorphic carcinoma of the breast. Virchows Arch. 456:31-37, 2010.
PubMed
P.175 掲載の参考文献
日本乳癌学会 編:脂質分泌癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.32.
 
黒住昌史, ほか:授乳期乳腺. 電子顕微鏡でみるミクロの世界-生物編(日本電子顕微鏡学会 編). 東京:学際企画;1995, pp.282-283.
 
黒住昌史:Lipid-secreting carcinoma. <生検鑑別診断アトラス>乳腺生検診断-進め方・考え方(長村義之ほか 編). 東京:文光堂;1997, pp.174-175.
 
黒住昌史, ほか:ヒト授乳期乳腺と分泌機能を有する特殊型乳癌の電子顕微鏡学的所見. 日本臨床電子顕微鏡学会誌 33:9-30, 2000.
 
Ellis IO, et al. :Lipid-rich carcinoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.41-42.
 
Eusebi V, et al. :Lipid-rich carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, p.74.
 
Koerner FC:Lipid-rich carcinoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.833-836.
 
Kurosumi K, et al. :The fine structure of mammary glands of lactating rats, with special reference to the apocrine secretion. Exp Cell Res. 50:177-192, 1968.
 
Kurosumi M, et al. :Lipid-secreting mammary carcinoma:A light and electron microscopic investigation. J Clin Electron Micr. 21:147-156, 1988.
 
Rakha EA, et al:Lipid-rich pattern. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, p.108.
 
P.179 掲載の参考文献
日本乳癌学会 編:グリコーゲン淡明細胞癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.32.
 
Akagi NE, et al. :Glycogen-rich clear cell carcinoma:a rare variant of breast carcinoma of uncertain significance. Int J Surg Pathol. 26:530-531, 2018.
PubMed
Ellis IO, et al. :Glycogen-rich clear cell carcinoma(GRCC). In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.28-29.
 
Eun NL, et al. :Clinical imaging of glycogen-rich clear cell carcinoma of the breast:a case series with literature review. Magn Reason Med Sci. 18:238-242, 2019.
 
Eusebi V, et al. :Glycogen-rich clear cell carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.74-75.
 
Koerner FC:Glycogen-rich carcinoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.837-844.
 
Ma X, et al. :Clinicopathologic characteristics and prognosis of glycogen-rich clear cell carcinoma of the breast. Breast J. 20:166-173, 2014.
PubMed
Rakha EA, et al:Glycogen-rich clear cell pattern. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.108-109.
 
Toikkanen S, et al. :Glycogen-rich clear cell carcinoma of the breast:a clinicopathologic, flow cytometric study. Hum Pathol. 22:81-83, 1991.
PubMed
Zhou Z, et al. :Clinical features, survival and prognostic factors of glycogen-rich clear cell carcinoma(GRCC)of the breast in the U. S. population. J Clin Med. 8:246, 2019.
 
P.183 掲載の参考文献
日本乳癌学会 編:好酸性癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.32.
 
Costa MJ, Silverberg SG:Oncocytic carcinoma of the male breast. Arch Pathol Lab Med. 113:1396-1399, 1989.
PubMed
Damiani S, et al. :Oncocytic carcinoma(malignant oncocytoma)of the breast. Am J Surg Pathol. 22:221-230, 1998.
PubMed
Dettori T, et al. :Aneuploidy in oncocytic lesions of the thyroid gland:Diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations. Genes Chromosomes Cancer. 38:22-31, 2003.
PubMed
Ellis IO, et al. :Oncocytic carcinoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.43-44.
 
Eusebi V, et al. :Oncocytic carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.72-73.
 
Guaraldi F, et al. :Oncocytic mania:a review of oncocytic lesions throughout the body. J Endocrinol Invest. 34:383-394, 2011.
 
Marla NJ, et al. :Male breast cancer-review of literature on a rare microscopic variant(oncocytic carcinoma). Indian J Surg. 75(Suppl 1):240-242, 2013.
 
Ragazzi M, et al. :Oncocytic carcinoma of the breast:frequency, morphology and follow-up.Hum Pathol. 42:166-175, 2011.
PubMed
Rakha EA, et al:Oncocytic pattern. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.107-108.
 
P.187 掲載の参考文献
日本乳癌学会 編:微小浸潤癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.28.
 
Cowell CF, et al. :Progression from ductal carcinoma in situ to invasive breast cancer:revisited. Mol Oncol. 7:859-869, 2013.
PubMed
Cserni G, et al:Microinvasive carcinoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.110-113.
 
Ellis IO, Tavassoli FA:Microinvasive carcinoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.74-75.
 
Hicks DG, Lester SC:Ductal carcinoma in situ with microinvasion. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.226-231.
 
Li Y, et al. :The clinical features and management of women with ductal carcinoma in situ with microinvasion:a retrospective Cohort study. Int J Surg. 19:91-94, 2015.
 
Matsen CB, et al. :Extent of microinvasion in ductal carcinoma in situ is not associated with sentinel lymph node metastases. Ann Surg Oncol. 21:3330-3335, 2014.
 
Pinder SE, et al. :Microinvasive carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.96-97.
 
Sakr RA, et al. :PI3K pathway activation in high-grade ductal carcinoma in situ implications for progression to invasive breast carcinoma. Clin Cancer Res. 20:2326-2337, 2014.
PubMed
Shatat L, et al. :Microinvasive breast carcinoma carries an excellent prognosis regardless of the tumor characteristics. Hum Pathol. 44:2684-2689, 2013.
PubMed
P.191 掲載の参考文献
日本乳癌学会 編:浸潤性小葉癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.29.
 
Hicks DG, Lester SC:Invasive lobular carcinoma. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.248-257.
 
Hicks DG, Lester SC:Invasive lobular carcinoma variants. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.258-263.
 
Hoda SA:Invasive lobular carcinoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.945-988.
 
Lakhani SR, et al. :Invasive lobular carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.40-42.
 
Shin SJ, et al. :Invasive lobular carcinoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.114-118.
 
P.197 掲載の参考文献
日本乳癌学会 編:管状癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.29.
 
黒住昌史ほか:一側乳房に多発病巣を有した乳腺の管状癌(tubular carcinoma). 乳癌の臨床 7:625-629, 1992.
Medical*Online
Aulmann S, et al. :Invasive tubular carcinoma of the breast frequently is clonally related to flat epithelial atypia and low-grade ductal carcinoma in situ. Am J Surg Pathol. 33:1646-1653, 2009.
PubMed
Brogi E:Tubular carcinoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.516-538.
 
Ellis IO, et al. :Tubular carcinoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.26-27.
 
Hicks DG, Lester SC:Tubular/cribriform carcinoma. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.264-271.
 
Lopez-Garcia MA, et al. :Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype-matched ductal and lobular carcinoma. J Pathol. 222:64-75, 2010.
PubMed
Man S et al. :High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. Cancer Res. 56:5484-5489, 1996.
 
Rakha E et al. :Tubular carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.43-45.
 
van Deurzen CHM et al. :Tubular carcinoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2018, pp.119-120.
 
P.203 掲載の参考文献
日本乳癌学会 編:篩状癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.30.
 
Abdel-Fatah TM, et al. :Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions:further evidence to support the concept of low nuclear grade breast neoplasia family. Am J Surg Pathol. 32:513-523, 2008.
PubMed
Ellis IO, et al. :Invasive cribriform carcinoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.27-28.
 
Ellis IO, et al. :Cribriform carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.44-45.
 
Hicks DG, Lester SC:Tubular/cribriform carcinoma. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.264-271.
 
Horlings HM, et al. :Genomic profiling of histological special types of breast cancer. Breast Cancer Res Treat. 142:257-269, 2013.
PubMed
Koerner FC:Invasive cribriform carcinoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.828-832.
 
Page DL, et al. :Invasive cribriform carcinoma of the breast. Histopathology. 7:525-536, 1983.
PubMed
van Deurzen CHM, et al. :Cribriform carcinoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.121-122.
 
Zhang W, et al. :Invasive cribriform carcinoma in a Chinese population:comparison with low-grade invasive ductal carcinoma-not otherwise specified. Int J Clin Exp Pathol. 6:445-457, 2013.
 
P.207 掲載の参考文献
日本乳癌学会 編:粘液癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.30.
 
黒住昌史ほか:乳腺のmucocele-like tumor(MLT)の細胞学, 組織化学および免疫組織化学的検討. 乳癌の臨床 7:417-420, 1992.
Medical*Online
黒住昌史ほか:乳房原発の argyrophilic mucinous carcinoma の1例. Mamma 17:22-23, 1993.
 
Brogi E:Mucinous carcinoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.665-706.
 
Bussolati G, Sapino A:Mucinous carcinoma and carcinomas with signet-ring-cell differentiation. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.60-61.
 
Domfeh AB, et al. :WT1 immunoreactivity in breast carcinoma. :selective expression in pure and mixed mucinous subtypes. Mod Pathol. 21:1217-1223, 2008.
PubMed
Ellis IO, et al. :Mucinous carcinoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.30-32.
 
Hicks DG, Lester SC:Mucinous(colloid)carcinoma. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.282-291.
 
Kurosumi M, et al. :Fine needle aspiration cytology of argyrophilic mucinous carcinoma of the male breast. Breast Cancer. 3:53-56, 1996.
 
Wen HY, et al. :Mucinous carcinoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.123-125.
 
P.211 掲載の参考文献
日本乳癌学会 編:浸潤性微小乳頭癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.31.
 
Brogi E:Invasive micropapillary carcinoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.845-863.
 
Ellis IO, et al. :Invasive micropapillary carcinoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.35-36.
 
Gruel N, et al. :Polarity gene alterations in pure invasive micropapillary carcinomas of the breast. Breast Cancer Res. 16:R46, 2014.
PubMed
Hicks DG, Lester SC:Invasive micropapillary carcinoma. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.298-305.
 
Marchio C, et al. :Invasive micropapillary carcinoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.128-130
 
Natrajan R, et al. :Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast. J Pathol. 232:553-565, 2014.
PubMed
Reis-Fiho JS, Ellis IO:Invasive micropapillary carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.65-66.
 
Stewart RL, et al. :HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features. Mod Pathol. 30:1561-1566, 2017.
PubMed
Troxell ML:Reversed MUC1/EMA polarity in both mucinous and micropapillary breast carcinoma. Hum Pathol. 45:432-434, 2014.
PubMed
P.215 掲載の参考文献
日本乳癌学会 編:アポクリン癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.30.
 
黒住昌史ほか:乳腺のアポクリン癌(apocrine carcinoma)の細胞学および電子顕微鏡学的所見. 乳癌の臨床 8:403-408, 1993.
Medical*Online
Banneau G, et al. :Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations. Breast Cancer Res. 12:R63, 2010.
PubMed
Brogi E:Apocrine carcinoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.707-731.
 
Ellis IO, et al. :Apocrine carcinoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.36-37.
 
Hicks DG, Lester SC:Invasive apocrine carcinoma. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.366-371.
 
Kurosumi M, Sakamoto M:Electron microscopic studies of primary apocrine carcinoma of the breast. Med Electron Microsc. 27:113-122, 1994
 
Lakis S, et al. :The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping. Breast. 23:234-243, 2014.
PubMed
O'Malley F, et al. :Carcinomas with apocrine differentiation. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.53-54.
 
Provenzano E, et al. :Carcinoma with apocrine differentiation. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.131-133.
 
P.223 掲載の参考文献
日本乳癌学会 編:化生癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, pp.30-31.
 
Altaf FJ, et al. :Metaplastic carcinoma of the breast:immunohistochemical study. Diagn Pathol. 9:139, 2014.
PubMed
Brogi E:Carcinoma with metaplasia. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.592-649.
 
Hicks DG, Lester SC:Metaplastic carcinoma. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.306-315.
 
Reis-Fiho JS, et al. :Metaplastic carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.48-52.
 
Reis-Fiho JS, et al. :Metaplastic carcinoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.134-138.
 
Tavassoli FA, Devilee P:Metaplastic carcinoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.37-41.
 
Wargotz ES, et al. :Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. Hum Pathol. 20:732-740, 1989.
PubMed
Wargotz ES, Norris HJ:Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer. 64:1490-1499, 1989.
PubMed
Weigelt B, et al. :Metaplastic breast carcinomas display genomic and transcriptomic heterogeneity. Mod Pathol. 28:340-351, 2015.
PubMed
P.231 掲載の参考文献
日本乳癌学会 編:腺様嚢胞癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.31.
 
Brogi E:Adenoid cystic carcinoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.799-827.
 
Ellis IO, et al. :Adenoid cystic carcinoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.44-45.
 
Fehr A, et al. :The MYB-NFIB gene fusion-a novel genetic link between adenoid cystic carcinoma and dermal cylindroma. J Pathol. 224:322-327, 2011.
PubMed
Foschini MP, et al. :Adenoid cystic carcinoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.142-145.
 
Hicks DG, Lester SC:Adenoid cystic carcinoma. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.332-341.
 
Mastropasqua MG, et al. :Immunoreactivity for c-kit and p63 as an adjunction the diagnosis of adenoid cystic carcinoma of the breast. Mod Pathol. 18:1277-1282, 2005.
PubMed
Sapino A, et al. :Adenoid cystic carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.56-57.
 
Vranic S, et al. :A review of adenoid cystic carcinoma of the breast with emphasis on its molecular and genetic characteristics. Hum Pathol. 44:301-309, 2013.
PubMed
Wetterskog D, et al. :Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers. J Pathol. 226:84-96, 2012.
PubMed
Wetterskog D, et al. :Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but not KIT mutations. Histopathology. 62:543-550, 2013.
 
P.235 掲載の参考文献
日本乳癌学会 編:分泌癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.31.
 
Arce C, et al. :Secretory carcinoma of the breast containing ETV6-NTRK3 fusion gene in a male:case report and review of the literature. World J Surg Oncol. 3:35, 2005.
 
Ellis IO, et al. :Secretory carcinoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.42-43.
 
Eusebi V, et al. :Secretory carcinoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.71-72.
 
Hicks DG, Lester SC:Secretory carcinoma. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.342-349.
 
Koerner FC:Secretory carcinoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.762-776.
 
Krings G, et al:Secretory carcinoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.146-148.
 
Lambros MB, et al. :Genomic profile of a secretory breast cancer with a ETV6-NTRK3 duplication. J Clin Pathol. 62:604-612, 2009.
PubMed
Makretsov N, et al. :A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma. Genes Chromosomes Cancer. 40:152-157, 2004.
 
Wong M, et al. :ETV6 disruption does not predict indolent clinical behavior in secretory breast carcinoma. Breast J. 18:604-606, 2012.
 
P.239 掲載の参考文献
日本乳癌学会 編:神経内分泌癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.32.
 
Brogi E:Mammary carcinoma with endocrine features. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.732-751.
 
Bussolati G, Badve S:Carcinoma with neuroendocrine features. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.62-63.
 
Hicks DG, Lester SC:Carcinoma with neuroendocrine features. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.372-379.
 
Rakha EA, et al:Neuroendocrine tumour. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.156-158.
 
P.243 掲載の参考文献
日本乳癌学会 編:神経内分泌癌. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.32.
 
Brogi E:Mammary carcinoma with endocrine features. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.732-751.
 
Bussolati G, Badve S:Carcinoma with neuroendocrine features. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.62-63.
 
Ellis IO, et al. :Neuroendocrine tumours. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.32-34.
 
Hicks DG, Lester SC:Carcinoma with neuroendocrine features. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.372-379.
 
Koerner FC:Small cell carcinoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.752-761.
 
McCullar B, et al. :Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung. Breast Cancer Res Treat. 158:195-202, 2016.
PubMed
Rakha EA, et al:Neuroendocrine carcinoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.159-161.
 
Rekhtman N, et al. :Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets. Clin Cancer Res. 22:3618-3629, 2016.
PubMed
Shin SJ, et al. :Small cell carcinoma of the breast:a clinicopathologic and immunohistochemical study of nine patients. Am J Surg Pathol. 24:1231-1238, 2000.
PubMed
P.249 掲載の参考文献
日本乳癌学会 編:過誤腫. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.36.
 
Bellocq JP, et al. :Mammary hamartomas. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, p.103.
 
Daya D, et al. :Hamartoma of the breast, an underrecognized breast lesion. A clinicopathologic and radiographic study of 25 cases. Am J Clin Pathol. 103:685-689, 1995.
PubMed
Georgian-Smith D, et al. :The mammary hamartoma:appreciation of additional imaging characteristics. J Ultrasound Med. 23:1267-1273, 2004.
PubMed
Herbert M, et al. :Breast hamartomas:clinicopathological and immunohistochemical studies of 24 cases. Histopathology. 41:30-34, 2002.
PubMed
Hicks DG, Lester SC:Hamartoma. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.84-87.
 
Pilarski R, et al. :Cowden syndrome and the PTEN hamartoma tumor syndrome:systematic review and revised diagnostic criteria. J Natl Cancer Inst. 105:1607-1616, 2013.
PubMed
Sevim Y, et al. :Breast hamartoma:a clinicopathologic analysis of 27 cases and a literature review. Clinics(Sao Paulo)69, 515-523, 2014.
 
Tan PH, et al. :Hamartoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, p.147.
 
Tse G, et al. :Hamartoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.166-167.
 
P.253 掲載の参考文献
日本乳癌学会 編:線維腺腫. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, pp.32-33.
 
Bellocq JP, et al. :Fibroadenoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.99-100.
 
Brogi E:Fibroadenoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.228-248.
 
Carney JA, et al. :Myxoid fibroadenoma and allied conditions(myxomatosis)of the breast. A heritable disorder with special associations including cardiac and cutaneous myxomas. Am J Surg Pathol. 15:713-721, 1991.
PubMed
Hicks DG, Lester SC:Fibroadenoma. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.496-503.
 
Kurosumi M, et al. :Invasive ductal carcinoma with a predominant intraductal component arising in a fibroadenoma of the breast. Pathol Int. 44:874-877, 1994.
 
Lim WK, et al. :Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma. Nat Genet. 46:877-880, 2014.
PubMed
Tan PH, et al. :Fibroadenoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.142-143.
 
Thike AA, et al. :Fibroadenoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.168-171.
 
Wu YT, et al. :Breast cancer arising within fibroadenoma:collective analysis of case reports in the literature and hints on treatment policy. World J Surg Oncol. 12:335, 2014.
PubMed
P.260 掲載の参考文献
日本乳癌学会 編:葉状腫瘍. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.33.
 
Bellocq JP, et al. :Phyllodes tumour. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.100-103.
 
Brogi E:Phyllodes tumor. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.248-289.
 
Hicks DG, Lester SC:Phyllodes tumor. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.504-513.
 
Jones AM, et al. :mRNA expression profiling of phyllodes tumours of the breast:identification of genes important in the development of borderline and malignant phyllodes tumours. J Pathol. 216:408-417, 2008.
PubMed
Lacroix-Triki M, et al. :β-catenin/Wnt signaling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast. Mod Pathol. 23:1438-1448, 2010.
 
Lin JJ, et al. :Malignant phyllodes tumorsdisplay mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells. Breast Cancer Res. 16:R29, 2014.
PubMed
Tan PH, et al. :Phyllodes tumour. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.143-147.
 
Tan WJ, et al. :CD117 expression in breast phyllodes tumors correlates with adverse pathologic parameters and reduced survival. Mod Pathol. 28:352-358, 2015.
PubMed
Tse G, et al. :Phyllodes tumour. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.172-176.
 
P.269 掲載の参考文献
日本乳癌学会 編:乳頭部腺腫. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.26.
 
DI Bonito M, et al. :Adenoma of the nipple:clinicopathological report of 13 cases. Oncol Lett. 7:1839-1842, 2014.
PubMed
Eusebi V, et al. :Nipple adenoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, p.104.
 
Eusebi V, Lester S:Nipple adenoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, p.150.
 
Hicks DG, Lester SC:Nipple adenoma. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.156-161.
 
Koerner FC:Florid papillomatosis of the nipple. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.129-140.
 
Jones MW, et al. :Coexistence of nipple duct adenoma and breast carcinoma:a clinicopathologic study of five cases and review of the literature. Mod Pathol. 8:633-666, 1995.
PubMed
Lester SC, et al. :Nipple adenoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.182-183.
 
Myers JL, et al. :Florid papillomatosis of the nipple:immunohistochemical and flow cytometric analysis of two cases. Mod Pathol. 3:288-293, 1990.
PubMed
Rosen PP, et al. :Florid papillomatosis of the nipple. A study of 51 patients, including nine with mammary carcinoma. Am J Surg Pathol. 10:87-101, 1986.
PubMed
P.275 掲載の参考文献
日本乳癌学会 編:Paget病. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.32.
 
黒住昌史:乳房の悪性疾患-Paget病の臨床的特徴. <新女性医学大系 20>乳房とその疾患. 東京:中山書店;1999, pp.262-269.
 
Albarracin CT, et al. :Paget disease of the breast. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.184-185.
 
Brachtel EF, Koerner FC:Paget disease of the nipple. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5thed. Philadelphia:Wolters Kluwer;2021, pp.864-885.
 
Hicks DG, Lester SC:Ductal carcinoma in situ, Paget disease. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.216-225.
 
Lee HW, et al. :Invasive Paget disease of the breast:20 years of experience at a single institution. Hum Pathol. 45:2480-2487, 2014.
 
Shousha S, et al. :Paget disease. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.152-153.
 
Tavassoli FA, et al. :Paget disease of the breast. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.105-106.
 
P.281 掲載の参考文献
Antonescu CR, et al. :Postradiation angiosarcoma of the breast. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.197-199.
 
Behjati S, et al. :Recurrent PTPRB and PLCG1 mutations in angiosarcoma. Nat Genet. 46:376-379, 2014.
PubMed
Billings SD, et al. :Cutaneous angiosarcoma following breast-conserving surgery and radiation:an analysis of 27 cases. Am J Surg Pathol. 28:781-788, 2004.
PubMed
Brenn T, et al. :Radiation-associated cutaneous atypical vascular lesions and angiosarcoma:clinicopathologic analysis of 42 cases. Am J Surg Pathol. 29:983-986, 2005.
PubMed
Fisher C:Unusual myoid, perivascular, and postradiation lesions, with emphasis on atypical vascular lesion, postradiation cutaneous angiosarcoma, myoepithelial yumors, myopericytoma, and perivascular epithelioid cell tumor. Semin Diagn Pathol. 30:73-84, 2013.
PubMed
Huang SC, et al. :Recurrent CIC gene abnormalities in angiosarcomas:a molecular study of 120 cases with concurrent investigation of PLCG1, KDR, MYC, and FLT4 gene alterations. Am J Surg Pathol. 40:645-655, 2016.
PubMed
Kirova YM, et al. :Radiation-induced sarcomas after radiotherapy for breast carcinoma:a large-scale single-institution review. Cancer. 104:856-863, 2005.
PubMed
Koerner FK:Postiradiation angiosarcoma and cutaneous atypical vascular lesion. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.1256-1270.
 
Nascimento AF, et al. :Primary angiosarcoma of the breast:clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic. Am J Surg Pathol. 32:1896-1904, 2008.
 
Vorburger SA, et al. :Angiosarcoma of the breast. Cancer. 104:2682-2688, 2005.
PubMed
P.285 掲載の参考文献
日本乳癌学会 編:血管肉腫. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.34.
 
Al-Abbadi MA, et al. :Cytokeratin and epithelial membrane antigen expression in angiosarcomas:an immunohistochemical study of 33 cases. Arch Pathol Lab Med. 131:288-292, 2007.
PubMed
Antonescu C:Malignant vascular tumors-an update. Mod Pathol. 27(Suppl1):S30-S38, 2014.
 
Antonescu CR, et al. :Primary angiosarcoma of the breast. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.200-201.
 
Drijkoningen M, et al. :Angiosarcoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.94-96.
 
Fletcher CD, et al. :Epithelioid angiosarcoma of deep soft tissue:a distinctive tumor readily mistaken for an epithelial neoplasm. Am J Surg Pathol. 15:915-924, 1991.
 
Fletcher CDM, et al. :Angiosarcoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.135-136.
 
Gervais MK, et al. :Clinical outcomes in breast angiosarcoma patients:a rare tumor with unique challenges. J Surg Oncol. 116:1056-1061, 2017.
PubMed
Hicks DG, Lester SC:Angiosarcoma. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.564-571.
 
Koerner FK:Sporadic angiosarcoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.1241-1256.
 
P.291 掲載の参考文献
日本乳癌学会 編:顆粒細胞腫. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.34.
 
Bui M, et al. :Granular cell tumour. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019 pp.215-216.
 
Drijkoningen M, et al. :Granular cell tumour. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, p.94.
 
Fox SB, et al. :Granular cell tumour. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.134-135.
 
Goldblum JR, et al. :Granular cell tumor. In:Enzinger & Weiss's Soft Tissue Tumors, 6th ed. St. Louis:Mosby;2014, pp.831-845.
 
Hicks DG, Lester SC:Granular cell tumor. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.534-539.
 
Lerwill MF, et al. :Granular cell tumor. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.1156-1160.
 
Young B, et al. :神経組織. 機能を中心とした図説 組織学, 第5版(澤田元ほか訳), 東京:医学書院;2019, pp.122-150.
 
P.295 掲載の参考文献
日本乳癌学会 編:Pseudoangiomatous stromal hyperplasia. 臨床・病理 乳癌取扱い規約, 第 18 版. 東京:金原出版;2018, p.34.
 
Drijkoningen M, et al. :Pseudoangiomatous stromal hyperplasia. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, pp.90-91.
 
Hicks DG, Lester SC:Pseudoangiomatous stromal hyperplasia. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.514-517.
 
Ibrahim RE, et al. :Pseudoangiomatous hyperplasia of mammary stroma. Some observations regarding its clinicopathologic spectrum. Cancer. 63:1154-1160, 1989.
PubMed
Lerwill MF, Koerner FC:Pseudoangiomatous hyperplasia of mammary stroma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.1135-1144.
 
Malik D, et al. :68Ga-PSMA expression in Pseudoangiomatous stromal hyperplasia of the breast. Clin Nucl Med. 42:58-60, 2017.
PubMed
Michal M, et al. :Pseudoangiomatous stromal hyperplasia. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.129-130.
 
Powell CM, et al. :Pseudoangiomatous stromal hyperplasia(PASH). A mammary stromal tumor with myofibroblastic differentiation. Am J Surg Pathol. 19:270-277, 1995.
 
Rowe JJ, et al. :Pseudoangiomatous stromal hyperplasia. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.228-230.
 
Vuitch MF, et al. :Pseudoangiomatous hyperplasia of mammary stroma. Hum Pathol. 17:185-191, 1986.
PubMed
P.301 掲載の参考文献
日本乳癌学会 編:悪性リンパ腫. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.35.
 
Aviv A, et al. :Primary diffuse large B-cell lymphoma of the breast:looking at pathogenesis, clinical issues and therapeutic options. Ann Oncol. 24:2236-2244, 2013.
PubMed
Ferry JA:Diffuse large B-cell lymphoma. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.1291-1294.
 
Hicks DG, Lester SC:Lymphoma. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.630-637.
 
Jaffe ES et al. :Diffuse large B-cell lymphoma. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.156-157.
 
Jia Y, et al. :Primary breast diffuse large B-cell lymphoma:a population-based study from 1975 to 2014. Oncotarget. 9:3956-3967, 2017.
PubMed
Lamovec J:Diffuse large B-cell lymphoma. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, p.108.
 
Medeiros LJ, Piris MA:Diffuse large B-cell lymphoma. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.240-241.
 
Pisani F, et al. :Diffuse large B-cell lymphoma involving the breast. A report of four cases. J Exp Clin Cancer Res. 25:277-281, 2006.
 
Talwalker SS, et al. :Lymphoma involving breast:a study of 106 cases comparing localized and disseminated neoplasms. Am J Surg Pathol. 32:1299-1309, 2008.
 
P.307 掲載の参考文献
日本乳癌学会 編:女性化乳房症. 臨床・病理 乳癌取扱い規約, 第18版. 東京:金原出版;2018, p.36.
 
Foschini MP, et al. :Gynecomastia. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.252-254.
 
Hicks DG, Lester SC:Gynecomastia. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.80-83.
 
Hoda SA:Gynecomastia. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.1060-1070.
 
Johnson RE, et al. :Gynecomastia:pathophysiology, evaluation, and management. Mayo Clin Proc. 84:1010-1015, 2009.
PubMed
Kono S, et al:Immunohistochemical study of the relationship between Ki-67 labeling index of proliferating cells of gynecomastia, histological phase and duration of disease. Pathol Int 56:655-658, 2006.
PubMed
Ma NS, et al. :Gynecomastia in prepubertal and pubertal men. Curr Opin Pediatr. 20:465-470, 2008.
PubMed
Narula HS, et al. :Gynaecomastia-pathophysiology, diagnosis and treatment. Nat Rev Endocrinol. 10:684-698, 2014.
PubMed
Prechtel K, et al. :Gynecomastia. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, p.110.
 
Reiner A, et al. :Gynecomastia. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, p.166-167.
 
P.311 掲載の参考文献
黒住昌史:男子乳癌. 最新・乳癌の診断と治療(泉雄 勝 編), 新訂第2版. 大阪:永井書店;1990, pp.311-321.
 
Brogi E:Carcinoma of the male breast. In:Hoda SA, et al. , editors, Rosen's Breast Pathology, 5th ed. Philadelphia:Wolters Kluwer;2021, pp.1073-1096.
 
Carder PJ, et al. :Expression of prostate specific antigen in male breast cancer. J Clin Pathol. 58:69-71, 2005.
PubMed
Foschini MP, et al. :Invasive carcinoma. Tumours of the male breast. In:the WHO classification of tumours editorial board, editors, Breast Tumours. WHO Classification of Tumours, 5th ed. Lyon:IARC Press;2019, pp.257-259.
 
Hicks DG, Lester SC:Breast carcinoma, male. In:Diagnostic Pathology:Breast, 2nd ed. Philadelphia:Elsevier;2016, pp.660-663.
 
Johansson I, et al. :Molecular profiling of male breast cancer-lost in transition? Int J Biochem Cell Biol. 53:526-535, 2014.
 
Nilsson C, et al. :High proliferation is associated with inferior outcome in male breast cancer patients. Mod Pathol. 26:87-94, 2013.
PubMed
Nilsson C, et al. :Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact. Acta Oncol. 52:102-109, 2013.
PubMed
Prechtel K, et al. :Carcinoma. Tumours of the male breast. In:Tavassoli FA, Devilee P, editors, Pathology and Genetics of Tumours of the Breast and Female Genital Organs. WHO Classification of Tumours, 3rd ed. Lyon:IARC Press;2003, p.110.
 
Shousha S, et al. :Carcinoma of the male breast. In:Lakhani SR, et al. , editors, WHO Classification of Tumours of the Breast, 4th ed. Lyon:IARC Press;2012, pp.168-169.
 

書評

最近チェックした商品履歴

Loading...